PD-1/PD-L1 blockade therapy with atezolizumab: a new paradigm in the treatment of non-small cell lung cancer (NSCLC)
2025 · Discover Oncology · 4 citations
https://doi.org/10.1007/s12672-025-02076-3
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
12
Papers
198
Citations
5
h-index
3
i10-index
Samaneh Moradi is an academic researcher from Kharazmi University. The author has contributed to research in topics: Protein Structure and Dynamics & MicroRNA in disease regulation & Cancer Immunotherapy and Biomarkers. The author has an h-index of 5, co-authored 11 publications.
https://doi.org/10.1007/s12672-025-02076-3
https://doi.org/10.1155/jfpp/8039409
Click to start Chat